This company has been marked as potentially delisted and may not be actively trading. Vaccitech (VACC) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisCompetitorsHeadlinesInsider TradesTrendsBuy This Stock Vaccitech (NASDAQ:VACC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.00%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$60.98KNumber OfInsiders Selling(Last 3 Years)3Amount OfInsider Selling(Last 3 Years)$147.83K Get VACC Insider Trade Alerts Want to know when executives and insiders are buying or selling Vaccitech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VACC Insider Buying and Selling by Quarter Vaccitech Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/26/2023Joseph ScheerenDirectorBuy10,000$2.44$24,400.00 5/25/2023Robin WrightDirectorBuy13,750$2.66$36,575.00 3/27/2023William EnrightCEOSell15,000$2.42$36,300.00 8/25/2022Graham GriffithsInsiderSell10,000$7.39$73,900.00 8/24/2022Christopher EllisCOOSell450$4.78$2,151.00 8/18/2022Christopher EllisCOOSell2,175$4.84$10,527.00 8/17/2022Graham GriffithsInsiderSell500$4.76$2,380.00 8/12/2022Graham GriffithsInsiderSell5,000$4.50$22,500.00 6/28/2022Christopher EllisCOOSell5$6.00$30.00 6/23/2022Graham GriffithsInsiderSell8$5.28$42.24 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. (Data available from 1/1/2013 forward) VACC Insider Trading Activity - Frequently Asked Questions Who is on Vaccitech's Insider Roster? The list of insiders at Vaccitech includes Christopher Ellis, Graham Griffiths, Joseph Scheeren, Robin Wright, and William Enright. Learn more on insiders at VACC. What percentage of Vaccitech stock is owned by insiders? 6.00% of Vaccitech stock is owned by insiders. Learn more on VACC's insider holdings. Which Vaccitech insiders have been buying company stock? The following insider purchased VACC shares in the last 24 months: Joseph Scheeren ($24,400.00). How much insider buying is happening at Vaccitech? Insiders have purchased a total of 10,000 VACC shares in the last 24 months for a total of $24,400.00 bought. More Insider Trading Tools from MarketBeat Related Companies SELLAS Life Sciences Group Insider Buying RAPT Therapeutics Insider Buying Nkarta Insider Buying Korro Bio Insider Buying Lyell Immunopharma Insider Buying Assembly Biosciences Insider Buying Greenwich LifeSciences Insider Buying Ironwood Pharmaceuticals Insider Buying TuHURA Biosciences Insider Buying Atossa Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Summer Stocks With Insider Buying and Analyst Support3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders Bought This page (NASDAQ:VACC) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccitech plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccitech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.